HHealthcare Read More 3 Reasons to Buy Eli Lilly StockJune 21, 2026 Eli Lilly (NYSE: LLY) has been firing on all cylinders. The stock is up 40% over the past…
MMedication Read More Scott Galloway says GLP-1 drugs are a ‘silver bullet’ for America’s woes, if we’re not ‘stupid enough’ to get in the wayJune 20, 2026 On June 12, SpaceX (NASDAQ: SPCX) had the biggest IPO on record, making $75 billion (1) — but…
MMedication Read More Warning issued over counterfeit weight-loss drugs labelled as retatrutideJune 20, 2026 Senior doctors from a hospital in Melbourne’s north are warning people against taking drugs being labelled as experimental…
MMedication Read More Do GLP-1 pills work as well as injections? Here’s what studies show about weight loss, side effectsJune 18, 2026 (NEXSTAR) – GLP-1 drugs, which have grown incredibly popular in recent years for their ability to help people…
MMedication Read More The Latest Ozempic Side Effect? It May Make You Less ViolentJune 18, 2026 Topline GLP-1 medications like Ozempic and Wegovy may reduce the risk of violent criminal behavior among current users,…
HHealthcare Read More Novo Nordisk comeback stirs as Wegovy pill wins UK approvalJune 13, 2026 The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s Wegovy (semaglutide) pill, marking another…
MMedication Read More New Weight Loss Drug Could Beat Ozempic’s Results—When It’s ComingJune 11, 2026 A new experimental weight loss drug from Eli Lilly could produce greater weight loss results than popular medications…
HHealthcare Read More Middle East Erupts Again: Buy these Healthcare ETFs Before the Next StrikeJune 9, 2026 The global geopolitical landscape has plunged into a deep state of uncertainty once again following a direct exchange…
MMedication Read More Can Wegovy Pill’s Rapid Uptake Give Novo Nordisk an Edge Over LLY?June 8, 2026 Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…
HHealthcare Read More Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 SuccessJune 6, 2026 The pharmaceutical industry is highly technical and incredibly competitive. That is on clear display right now in the…
HHealthcare Read More 3 Reasons Eli Lilly Remains a BuyJune 5, 2026 Eli Lilly (NYSE: LLY) became the first $1 trillion pharmaceutical company late last year, built on the strength…
BBusiness Read More US companies disclose huge Irish tax payments – The Irish TimesJune 5, 2026 United States companies have disclosed billions of euro in tax payments to the Republic for the first time,…